LIFE aTyr Pharma Inc

USD 2.00 0.09 4.438642
Icon

aTyr Pharma Inc (LIFE) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.00

+0.09 (+4.44)%

USD 0.14B

1.20M

N/A

N/A

Icon

LIFE

aTyr Pharma Inc (USD)
COMMON STOCK | NSD
USD 2.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.14B

N/A

USD 2.00

aTyr Pharma Inc (LIFE) Stock Forecast

N/A

Based on the aTyr Pharma Inc stock forecast from 0 analysts, the average analyst target price for aTyr Pharma Inc is not available over the next 12 months. aTyr Pharma Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of aTyr Pharma Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, aTyr Pharma Inc’s stock price was USD 2.00. aTyr Pharma Inc’s stock price has changed by -0.99% over the past week, +0.00% over the past month and +1.52% over the last year.

No recent analyst target price found for aTyr Pharma Inc
No recent average analyst rating found for aTyr Pharma Inc

Company Overview aTyr Pharma Inc

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pul...Read More

https://www.atyrpharma.com

10240 Sorrento Valley Road, San Diego, CA, United States, 92121

56

December

USD

USA

Adjusted Closing Price for aTyr Pharma Inc (LIFE)

Loading...

Unadjusted Closing Price for aTyr Pharma Inc (LIFE)

Loading...

Share Trading Volume for aTyr Pharma Inc Shares

Loading...

Compare Performance of aTyr Pharma Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for LIFE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To aTyr Pharma Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc -1.14 (-0.27%) USD107.38B 29.93 21.06

ETFs Containing LIFE

Symbol Name LIFE's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About aTyr Pharma Inc (LIFE) Stock

Stock Target Advisor's fundamental analysis for aTyr Pharma Inc's stock is Bearish.

Unfortunately we do not have enough data on LIFE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on LIFE's stock to indicate what its average analyst target is.

LIFE stock's Price/Earning ratio is 20.71. Our analysis grades LIFE stock's Price / Earning ratio at F. This means that LIFE stock's Price/Earning ratio is above 72% of the stocks in the Biotechnology sector in the NSD exchange. Based on this LIFE may be a overvalued for its sector.

The last closing price of LIFE's stock was USD 2.00.

The most recent market capitalization for LIFE is USD 0.14B.

Unfortunately we do not have enough analyst data on LIFE's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains aTyr Pharma Inc's stock.

As per our most recent records aTyr Pharma Inc has 56 Employees.

aTyr Pharma Inc's registered address is 10240 Sorrento Valley Road, San Diego, CA, United States, 92121. You can get more information about it from aTyr Pharma Inc's website at https://www.atyrpharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...